{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-23-004464","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.378173+00:00","generated_at":"2026-06-13T14:52:35.473967+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Organicell appoints Howard Golub as EVP/CSO; 30+ years in clinical therapeutics","bullets":["Howard L. Golub, MD, PhD appointed EVP and Chief Science Officer effective June 29, 2023.","Dr. Golub brings over 30 years of clinical research experience, including VP R&D at Walgreens Boots Alliance and founding CareStat LLC.","He will lead Organicell's R&D for innovative regenerative biologic therapies.","CEO Harry Leider stated the appointment strengthens the company's research leadership."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-23-004464","json":"https://secwatch.observer/filing/0001829126-23-004464.json","markdown":"https://secwatch.observer/filing/0001829126-23-004464.md","text":"https://secwatch.observer/filing/0001829126-23-004464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623004464/0001829126-23-004464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623004464/organicellrege_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T14:52:35.473967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}